Evidence map›Paper›PMID 24699359›Full record

ArticlePLoS genetics2014

Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.

Amy L Stark, Ronald J Hause, Lidija K Gorsic, Nirav N Antao, Shan S Wong, Sophie H Chung, Daniel F Gill, Hae K Im, Jamie L Myers, Kevin P White and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2015
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Amy L StarkDepartment of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Ronald J HauseCommittee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America; Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America; Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America.
Lidija K GorsicDepartment of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Nirav N AntaoDepartment of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Shan S WongDepartment of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Sophie H ChungCommittee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America.
Daniel F GillCommittee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America.
Hae K ImDepartment of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
Jamie L MyersDepartment of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Kevin P WhiteCommittee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America; Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America; Department of Human Genetics, The University of Chicago, Chicago, Illinois, United States of America.
Richard Baker JonesCommittee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America; Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America; Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America; Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois, United States of America.
M Eileen DolanDepartment of Medicine, The University of Chicago, Chicago, Illinois, United States of America; Committee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America; Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois, United States of America.
University of Chicago · US

Funding

Whole GenomeU01GM061393 · NIGMS · UNIVERSITY OF CHICAGO · PI RATAIN, MARK J · 2000 to 2014
$39.0M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
PREDOCTORAL TRAINING IN GENETICS AND REGULATIONT32GM007197 · NIGMS · UNIVERSITY OF CHICAGO · PI ROTHMAN-DENES, LUCIA B. B · 1985 to 2020
$17.0M
Variation in Hormone and xenobiotic metabolizing enzyme genes and breast cancerP50CA125183 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F. · 2006 to 2010
$11.3M
Developing an Oncology Workforce for the 21st Century - Renewal 01K12CA139160 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F., SMITH, SONALI · 2010 to 2024
$10.6M
Modeling the temporal succession of phenotypes & environnnental cuesP50MH094267 · NIMH · UNIVERSITY OF CHICAGO · PI RZHETSKY, ANDREY · 2011 to 2015
$10.2M
Genetic determinants associated with pemetrexed response and toxicityR01CA136765 · NCI · UNIVERSITY OF CHICAGO · PI DOLAN, MARY EILEEN · 2009 to 2013
$1.6M
Re-Engineering Translational Research at The University of Chicago (TL1)TL1RR025001 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$303k
Re-Engineering Translational Research at the University of ChicagoTL1TR000432 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$289k
NCATS NIH HHS TL1 TR000432NCATS NIH HHS UL1 TR000430NCI NIH HHS K12 CA139160NCI NIH HHS P50 CA125183NCI NIH HHS R01 CA136765NCRR NIH HHS TL1 RR025001NCRR NIH HHS TL1 RR25001NIGMS NIH HHS T32 GM007197NIGMS NIH HHS T32 GM07197NIGMS NIH HHS U01 GM061393NIGMS NIH HHS UO1GM61393NIMH NIH HHS P50 MH094267NIMH NIH HHS P50-MH094267
6 · The paper itself

Abstract

Annotating and interpreting the results of genome-wide association studies (GWAS) remains challenging. Assigning function to genetic variants as expression quantitative trait loci is an expanding and useful approach, but focuses exclusively on mRNA rather than protein levels. Many variants remain without annotation. To address this problem, we measured the steady state abundance of 441 human signaling and transcription factor proteins from 68 Yoruba HapMap lymphoblastoid cell lines to identify novel relationships between inter-individual protein levels, genetic variants, and sensitivity to chemotherapeutic agents. Proteins were measured using micro-western and reverse phase protein arrays from three independent cell line thaws to permit mixed effect modeling of protein biological replicates. We observed enrichment of protein quantitative trait loci (pQTLs) for cellular sensitivity to two commonly used chemotherapeutics: cisplatin and paclitaxel. We functionally validated the target protein of a genome-wide significant trans-pQTL for its relevance in paclitaxel-induced apoptosis. GWAS overlap results of drug-induced apoptosis and cytotoxicity for paclitaxel and cisplatin revealed unique SNPs associated with the pharmacologic traits (at p<0.001). Interestingly, GWAS SNPs from various regions of the genome implicated the same target protein (p<0.0001) that correlated with drug induced cytotoxicity or apoptosis (p ≤ 0.05). Two genes were functionally validated for association with drug response using siRNA: SMC1A with cisplatin response and ZNF569 with paclitaxel response. This work allows pharmacogenomic discovery to progress from the transcriptome to the proteome and offers potential for identification of new therapeutic targets. This approach, linking targeted proteomic data to variation in pharmacologic response, can be generalized to other studies evaluating genotype-phenotype relationships and provide insight into chemotherapeutic mechanisms.

Indexed as

Antineoplastic AgentsApoptosisCell Line, TumorCisplatinGenome, HumanGenome-Wide Association StudyGenotypeHapMap ProjectHumansPaclitaxelPharmacogeneticsPhenotypePolymorphism, Single NucleotideProteinsProteomeProteomicsAntineoplastic AgentsCisplatinPaclitaxelProteinsProteomeTranscription Factors

Identifiers

PMID24699359
PMCPMC3974641
OpenAlexW2069440129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.